New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 20, 2012
09:18 EDTDFS, JBL, ELOQ, ICE, BBBY, RAD, VVUS, NYX, FOLD, CAG, ORCL, MDRXOn The Fly: Pre-market Movers
HIGHER AFTER EARNINGS: Rite Aid (RAD), up 17.3%... Jabil Circuit (JBL), up 5.4%... ConAgra (CAG), up 3.1%... ALSO HIGHER: NYSE Euronext (NYX), up 40.2% after acquisition by IntercontinentalExchange (ICE) for $33.12 per share in case and stock... Eloqua (ELOQ), up 30% after agreeing to be bought by Oracle (ORCL) for $23.50... VIVUS (VVUS), up 7.9% after Express Scripts (ESRX) adds Qsymia to formulary, takeover speculation fueled by Daily Mail report... LOWER AFTER EARNINGS: Bed Bath & Beyond (BBBY), down 5.8%... Discover (DFS), down 2.2%... ALSO LOWER: Amicus Therapeutics (FOLD), down 43.5% after drug doesn't show statistical benefit in study... Allscripts (MDRX), down 15.9% after evaluation of strategic alternatives ends without sale, CEO steps down.
News For NYX;ICE;MDRX;VVUS;ELOQ;ORCL;RAD;JBL;CAG;BBBY;DFS;FOLD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 3, 2015
14:36 EDTFOLDAmicus Therapeutics March volatility elevated into O4 and outlook
Subscribe for More Information
11:25 EDTVVUSOrexigen surges after disclosing weight loss drug data, patent news
Shares of Orexigen (OREX) are surging in morning trading after the company disclosed the data from the 25% interim analysis of the LIGHT cardiovascular study when announcing a method of treatment patent was issued for its weight loss drug, Contrave. In the filing, the company disclosed that Contrave demonstrated a statistically significant benefit over placebo for cardiovascular events, including CV death. ANALYST OPINION: The new patent announced today extends protection for Contrave to 2034, analysts at Piper Jaffray stated. The firm thinks the new data could possibly drive a competitive advantage in the U.S. market for Contrave, and enhance probability of approvals outside the U.S. It kept an Overweight rating on Orexigen and raised its price target on the stock to $26 from $16. Meanwhile, Leerink noted the data show a statistically significant Contrave benefit in the intent-to-treat population on MACE, myocardial infarction, stroke, and cardiovascular death. The firm believes the results "present meaningful upside to expectations" and could have a positive impact on the Contrave launch if they are included on the drug's labels. Leerink reiterates an Outperform rating on Orexigen. OTHERS TO WATCH: Other companies that offer weight loss drugs that compete with Contrave include VIVUS (VVUS) and Arena Pharmaceuticals (ARNA). PRICE ACTION: In morning trading, Orexigen shares surged 44.5% to $8.37, VIVUS shares rose 8% to $2.99 and Arena slid 3.5% to $4.13.
07:39 EDTICEIntercontinentalExchange growth stronger than appears, says UBS
Subscribe for More Information
February 27, 2015
21:14 EDTDFSDiscover management to meet with William Blair
Group luncheon to be held in New York on March 6 at 12:30 pm hosted by William Blair.
09:58 EDTMDRXOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: 500.com (WBAI) downgraded to Hold from Buy at Deutsche Bank... Akorn (AKRX) downgraded to Hold after share rally at Needham... Allscripts (MDRX) downgraded to Market Perform from Outperform at Leerink... Bank of America (BAC) downgraded to Neutral from Buy at UBS... Bill Barrett (BBG) downgraded to Hold from Buy at KLR Group... CA Technologies (CA) downgraded to Underperform from Neutral at Credit Suisse... CBOE Holdings (CBOE) downgraded at BofA/Merrill... CONE Midstream (CNNX) downgraded to Sector Perform from Outperform at RBC Capital... Calamos (CLMS) downgraded to Underperform from Neutral at Credit Suisse... Crane (CR) downgraded to Market Perform from Outperform at FBR Capital... Dick's Sporting (DKS) downgraded to Equal Weight from Overweight at Barclays... EnerNOC (ENOC) downgraded to Buy from Strong Buy at Needham... Hercules Offshore (HERO) downgraded to Sell from Buy at Deutsche Bank... Insulet (PODD) downgraded at Oppenheimer... Intelsat (I) downgraded to Underperform from Neutral at Credit Suisse... Laredo Petroleum (LPI) downgraded to Market Perform from Outperform at Northland... Mavenir Systems (MVNR) downgraded to Equal Weight from Overweight at Morgan Stanley... Memorial Production (MEMP) downgraded to Underperform from Perform at Oppenheimer... Mobileye (MBLY) downgraded to Neutral from Buy at Dougherty... NTELOS (NTLS) downgraded to Market Perform from Outperform at Wells Fargo... Ocwen (OCN) downgraded to Sell from Neutral at Compass Point... Pegasystems (PEGA) downgraded to Neutral from Buy at Merriman... Performant Financial (PFMT) downgraded to Neutral from Buy at Compass Point... Pharmacyclics (PCYC) downgraded to Neutral from Buy at Goldman... Potbelly (PBPB) downgraded to Underweight from Overweight at Piper Jaffray... SYNNEX (SNX) downgraded to Hold from Buy at Stifel... Safe Bulkers (SB) downgraded at Credit Suisse... Sarepta (SRPT) downgraded to Market Perform from Outperform at Cowen... Seadrill Partners (SDLP) downgraded to Sector Perform from Outperform at RBC Capital... Spirit Realty (SRC) downgraded at RBC Capital... Transocean (RIG) downgraded to Sector Perform from Outperform at Iberia... UIL Holdings (UIL) downgraded to Neutral from Outperform at RW Baird... WCI Communities (WCIC) downgraded to Neutral from Buy at Citigroup... Walter Investment (WAC) downgraded to Neutral from Outperform at Credit Suisse.
05:36 EDTMDRXAllscripts downgraded to Market Perform from Outperform at Leerink
Leerink downgraded Allscripts to Market Perform with a $13 price target citing slowing market demand following the company's Q4 results.
February 26, 2015
16:11 EDTMDRXAllscripts sees 2015 EPS 42c-50c, consensus 47c
Subscribe for More Information
16:11 EDTMDRXAllscripts reports Q4 EPS 9c, consensus 9c
Subscribe for More Information
15:30 EDTMDRXNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Monster Beverage (MNST), consensus 59c... Ross Stores (ROST), consensus $1.11... Gap (GPS), consensus 74c... Autodesk (ADSK), consensus 24c... Universal Health Services (UHS), consensus $1.50... Southwestern Energy (SWN), consensus 50c... Ensco (ESV), consensus $1.36... J.C. Penney (JCP), consensus 11c... Nimble Storage (NMBL), consensus (14c)... Herbalife (HLF), consensus $1.22... Allscripts Healthcare (MDRX), consensus 9c... SBA Communications (SBAC), consensus 2c... Aruba Networks (ARUN), consensus 27c... Splunk (SPLK), consensus 4c... Air Lease (AL), consensus 61c... Ingram Micro (IM), consensus 99c... Weight Watchers (WTW), consensus 7c... Northern Oil and Gas (NOG), consensus 19c... Envision Healthcare (EVHC), consensus 36c... Infoblox (BLOX), consensus 5c... Live Nation (LYV), consensus (41c)... OmniVision (OVTI), consensus 29c... Bonanza Creek Energy (BCEI), consensus 27c.
06:46 EDTDFSDeutsche sees American Express as undervalued, upgrades to Buy
Subscribe for More Information
February 25, 2015
09:36 EDTBBBYBed Bath & Beyond Q4 comp sales trending below conensus, says Cleveland Research
Subscribe for More Information
February 24, 2015
16:01 EDTVVUSVIVUS reports Q4 EPS (25c), consensus (25c)
Reports Q4 revenue $21.7M, consensus $20.01M.
08:33 EDTFOLDArgos Therapeutics hires Joan Winterbottom as Chief Human Resources Officer
Argos Therapeutics (ARGS) announced that Joan Winterbottom will join the company as chief human resources officer. Winterbottom most recently served as senior vice president of human resources at Amicus Therapeutics (FOLD).
February 23, 2015
07:22 EDTFOLDSunTrust to hold a conference
2015 Biotechnology and Pharmaceutical 1:1 Orphan Drug Day is being held in New York on February 23.
06:06 EDTRADStocks with implied volatility movement; JNJ NUGT
Stocks with implied volatility movement; Halliburton (HAL) 32, Rite Aid (RAD) 34 according to iVolatility.
February 19, 2015
11:04 EDTORCLOracle unveils new big data solutions
Subscribe for More Information
February 18, 2015
06:32 EDTICEBATS Global Markets to replace CEO ahead of possible IPO, WSJ says
Subscribe for More Information
04:55 EDTORCLStocks with implied volatility movement; MO ORCL
Subscribe for More Information
February 17, 2015
08:01 EDTDFSDiscover January charge-offs 1.77% vs. 1.69% last month
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use